Get to know our clinical trials

Ensayo clínico de infusión de linfocitos T autólogos de sangre periférica expandidos y modificados genéticamente mediante transposones de la familia Sleeping Beauty para expresar un receptor antigénico quimérico con especificidad anti-CD19 conjugado ....l

THE OBJECTIVE OF THE STUDY IS: PHASE 1: - TO EVALUATE THE SAFETY OF TRANSPOCART19 CELL INFUSION IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL LYMPHOMA. - DETERMINE THE MAXIMUM TOLERATED DOSE (MTD) AND/OR RECOMMENDED DOSE OF TRANSPOCART19 CELLS IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL LYMPHOMA. PHASE 2: - TO EVALUATE THE EFFICACY OF TRANSPOCART19 CELL INFUSION IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL LYMPHOMA.

Cancer Center
Status
In recruitment
headquarters
Pamplona/Madrid

Technical Summary

  • PHASE I/IIA MULTICENTER STUDY OF INFUSION OF AUTOLOGOUS PERIPHERAL BLOOD T LYMPHOCYTES EXPANDED AND GENETICALLY MODIFIED USING SLEEPING BEAUTY FAMILY TRANSPOSONS TO EXPRESS A CHIMERIC ANTIGENIC RECEPTOR WITH ANTI-CD19 SPECIFICITY CONJUGATED TO THE 4-1BB CO-STIMULATORY REGION AND CD3Z AND HUEGFRT SIGNAL TRANSMISSION (TRANSPOCART19) IN PATIENTS WITH RELAPSED OR REFRACTORY B-CELL LYMPHOMA.
  • Code EudraCT: 2022-001040-23
  • Protocol number: TranspoCART19
  • Promoter: IBSAL

* The trials only admit a limited number of patients and are subject to inclusion and exclusion criteria. The specialist who assesses your case will inform you of the conditions required to participate in the clinical trial.

Who can participate?

Clinical trial of infusion of autologous peripheral blood T lymphocytes expanded and genetically modified using Sleeping Beauty family transposons to express a chimeric antigenic receptor with anti-CD19 specificity conjugated to ....l.

More information about this clinical trial

Information offered by the Spanish Registry of Clinical Studies

  • Summary
  • Information
  • Calendar
  • Headquarters
  • Drugs
Imagen de un icono azul con un fonendoscopio o estetoscopio.

Do you want to participate in this trial?

Request an appointment for our specialists to assess whether you qualify for this clinical trial


Imagen de un icono azul de un registro en el informe médico.

Do you prefer to send us your reports?

If you prefer, you can send us your medical information and our specialists will evaluate your case without the need to come to the Clinica.